Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16461322rdf:typepubmed:Citationlld:pubmed
pubmed-article:16461322lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:16461322lifeskim:mentionsumls-concept:C0037047lld:lifeskim
pubmed-article:16461322lifeskim:mentionsumls-concept:C0012634lld:lifeskim
pubmed-article:16461322lifeskim:mentionsumls-concept:C0026764lld:lifeskim
pubmed-article:16461322lifeskim:mentionsumls-concept:C0021149lld:lifeskim
pubmed-article:16461322pubmed:issue2lld:pubmed
pubmed-article:16461322pubmed:dateCreated2006-2-7lld:pubmed
pubmed-article:16461322pubmed:abstractTextWe observed clustering of monoclonal B-cell disease in siblings being screened as allogeneic donors for patients with multiple myeloma (MM) scheduled for stem cell transplantation (SCT). Of 134 asymptomatic donors, the incidence of monoclonal B-cell disease was 8/84 in siblings and 1/50 in matched unrelated donors. From an analysis of five MM families scheduled for allogeneic SCT, monoclonal B-cell disease was detected in 8/27 siblings.lld:pubmed
pubmed-article:16461322pubmed:languageenglld:pubmed
pubmed-article:16461322pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16461322pubmed:citationSubsetIMlld:pubmed
pubmed-article:16461322pubmed:statusMEDLINElld:pubmed
pubmed-article:16461322pubmed:monthFeblld:pubmed
pubmed-article:16461322pubmed:issn1592-8721lld:pubmed
pubmed-article:16461322pubmed:authorpubmed-author:BehringerDirk...lld:pubmed
pubmed-article:16461322pubmed:authorpubmed-author:FinkeJürgenJlld:pubmed
pubmed-article:16461322pubmed:authorpubmed-author:EngelhardtMon...lld:pubmed
pubmed-article:16461322pubmed:authorpubmed-author:IhorstGabriel...lld:pubmed
pubmed-article:16461322pubmed:authorpubmed-author:RothBirgitBlld:pubmed
pubmed-article:16461322pubmed:issnTypeElectroniclld:pubmed
pubmed-article:16461322pubmed:volume91lld:pubmed
pubmed-article:16461322pubmed:ownerNLMlld:pubmed
pubmed-article:16461322pubmed:authorsCompleteYlld:pubmed
pubmed-article:16461322pubmed:pagination274-6lld:pubmed
pubmed-article:16461322pubmed:meshHeadingpubmed-meshheading:16461322...lld:pubmed
pubmed-article:16461322pubmed:meshHeadingpubmed-meshheading:16461322...lld:pubmed
pubmed-article:16461322pubmed:meshHeadingpubmed-meshheading:16461322...lld:pubmed
pubmed-article:16461322pubmed:meshHeadingpubmed-meshheading:16461322...lld:pubmed
pubmed-article:16461322pubmed:meshHeadingpubmed-meshheading:16461322...lld:pubmed
pubmed-article:16461322pubmed:meshHeadingpubmed-meshheading:16461322...lld:pubmed
pubmed-article:16461322pubmed:meshHeadingpubmed-meshheading:16461322...lld:pubmed
pubmed-article:16461322pubmed:meshHeadingpubmed-meshheading:16461322...lld:pubmed
pubmed-article:16461322pubmed:meshHeadingpubmed-meshheading:16461322...lld:pubmed
pubmed-article:16461322pubmed:year2006lld:pubmed
pubmed-article:16461322pubmed:articleTitleIncidence of monoclonal B-cell disease in siblings of patients with multiple myeloma.lld:pubmed
pubmed-article:16461322pubmed:publicationTypeLetterlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16461322lld:pubmed